Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App





Need for Rapid Containment Measures to Drive Growth of Global COVID-19 Detection Kits Market

By LabMedica International staff writers
Posted on 30 May 2020
The growth of the global COVID-19 detection kits market will be driven by the responsiveness of countries to contain the spread of the coronavirus and advancements in healthcare facilities.

These are the latest findings of Transparency Market Research Pvt. More...
Ltd. (Albany, NY, USA), a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. The World Health Organization (WHO) has declared the coronavirus as a global health emergency, following an outbreak of cases in several parts of the world. Currently, more than 180 countries have reported cases of coronavirus among individuals of all age groups. The vulnerability of all groups of people to the virus has created panic among the masses. Therefore, it is important to ramp up manufacturing of COVID-19 detection kits. The value of the COVID-19 detection kits market is continuously rising on account of advancements in healthcare facilities

The healthcare industry has recalibrated its focus on fighting the pandemic. Countries such as Italy, the US, and Spain have been the worst-hit by the pandemic. Therefore, the use of COVID-19 detection kits in these regions has increased by leaps and bounds. As India ramps up its pace of testing, several companies have come to the fore of the healthcare industry. India has also received testing kits from South Korea, which is an important dynamic of market growth. The success of testing facilities in India has been a primary driver of demand within the global market.

Despite strict containment measures such as lockdowns and ban on public gathering, the risk of virus spread remains high. Several healthcare professionals and entities, including the WHO, recommend rapid testing as the foremost strategy to control the virus. Increased number of tests has helped countries in flattening the curve of the COVID-19 spread. Furthermore, testing has also helped governments and state authorities in contact tracing of affected individuals. Thus, the manufacturing of COVID-19 detection kits has assumed significant importance in various parts of the world. The presence of a seamless industry for COVID-19 testing will play a vital role in driving sales across the global market. The development of test kits that can deliver results in less than six hours will play a defining role in the growth of the global COVID-19 detection kits market.

Related Links:
Transparency Market Research Pvt. Ltd.


Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.